EUCTR2004-004511-39-DE进行中（未招募）不适用
Double blind (observer Blind) Placebo controlled, clinical-experimental Study of the Phase II for the examination of the local tolerance by Duhring-Chamber-Test as well as open user trial of the product Arnikamed Gel
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •written informed consent
- •written informed data protection
- •healthy subjects with healthy, normal skin conditions
- •age more than 18 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years)
- •F.1.3.1 Number of subjects for this age range
排除标准
- •volunteers who do not fulfill any of the above described criteria
- •volunteers who are pregnant or breast feeding
- •skin irritation or disease
- •skin diseases or dermatological disorders
- •Volunteers with severe disorders
- •topical medication in the test areas
- •Participitation in a study in the last 6 months
- •Consumption of alcohol or drugs
研究者
相似试验
进行中（未招募）
不适用
doubleblind (observer blind), placebo-controlled, clinical-experimental study phase II in order to examine the local compatibility of Dr. Theiss Ringelblumen Salbe N by the duhring-chamber-test and in a open user trial - local compatibility test and open user trial with Dr. Theiss Ringelblumen Salbehealthy subjects with normal skin conditionsEUCTR2004-004466-33-DEDr. Theiss Naturwaren GmbH40
已完成
2 期
Effect of Three Turmeric- Boswellia Formulations in Exercise Induced Body PaiCTRI/2021/02/031142Arjuna Natural Private Limited200
进行中（未招募）
1 期
Trial to evaluate the safety, tolerability and blood concentrations of multiple doses of GSK2269557 in COPD patients.MedDRA version: 17.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 100000004855Chronic Obstructive Pulmonary DiseaseEUCTR2014-000313-31-DEGlaxoSmithKline Research & Development Ltd65
已完成
2 期
Ayurvedic treatment of hypothyroidism with help of Nano kanchanarCTRI/2022/11/047606Dean Faculty Of Ayurved Parul University76
进行中（未招募）
不适用
randomized, double blind, two-arm placebo controlled, 12-Month study of the effects of rimonabant 20 mg once daily on amount and activity of visceral fat in abdominally obese patients with metabolic syndrome. - Visceral fat reduction assessed by CT-scan On RImonabAntAbdominal ObesityMedDRA version: 9.1Level: LLTClassification code 10059179Term: Abdominal obesityEUCTR2005-002568-27-ITSANOFI-SYNTHELABO232